Longs' Options Limited After Walgreen's Exit
As the stock market plunged this week to its lowest level in years, Walgreen decided to keep its $3 billion and let Longs sell itself to CVS-Caremark (CVS) instead. Walgreen had topped CVS's $75-a-share bid by offering $75 a share for the regional drugstore chain.
"With the stock market revaluation we're witnessing even as we write this, we doubt this will be the last takeover bid launched in headier days that is withdrawn," Gimme Credit analyst Carol Levenson said in a research note Thursday. "CVS might also want to reconsider the premium it is paying for Longs and the value of its real estate, but it's probably gone too far to turn back now."
Just weeks ago, Longs shareholders were looking for a bidding war. Now, their options are limited. Either they accept CVS's $71.50 offer -- which they previously rejected as too low -- or they hold on to their stock in a tough market and hope for a better deal.That uncertainty is clearly reflected in Longs' stock, which fell 3.3% to $69.30 on Thursday. The stock now fetches $2 less than CVS has promised to pay. "I'm not sure if that reflects heavy selling from those who bought above the CVS offer price, or whether it shows some skepticism of the CVS deal getting done," says Richard Clayton, research director at CtW Investment Group. "Given the fact that we continue to see substantial deterioration in the credit markets, CVS can't repeat enough that it can actually do this deal."
Select the service that is right for you!COMPARE ALL SERVICES
Jim Cramer and Stephanie Link actively manage a real portfolio and reveal their money management tactics while giving advanced notice before every trade.
- $2.5+ million portfolio
- Large-cap and dividend focus
- Intraday trade alerts from Cramer
- Weekly roundups
Access the tool that DOMINATES the Russell 2000 and the S&P 500.
- Buy, hold, or sell recommendations for over 4,300 stocks
- Unlimited research reports on your favorite stocks
- A custom stock screener
- Upgrade/downgrade alerts
Jim Cramer's protege, David Peltier, identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.
- Diversified model portfolio of dividend stocks
- Alerts when market news affect the portfolio
- Bi-weekly updates with exact steps to take - BUY, HOLD, SELL
All of Real Money, plus 15 more of Wall Street's sharpest minds delivering actionable trading ideas, a comprehensive look at the market, and fundamental and technical analysis.
- Real Money + Doug Kass Plus 15 more Wall Street Pros
- Intraday commentary & news
- Ultra-actionable trading ideas
Our options trading pros provide daily market commentary and over 100 monthly option trading ideas and strategies to help you become a well-seasoned trader.
- 100+ monthly options trading ideas
- Actionable options commentary & news
- Real-time trading community
- Options TV